Significant Ownership of Xuncheng Chen
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Xuncheng Chen focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Shanwei
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
1 identity field
Follow Filing Activity
Follow Xuncheng Chen with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Xuncheng Chen
Significant Ownership of Xuncheng Chen
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| UPC | Universe Pharmaceuticals INC | Class A ordinary shares | 9.9% | $3,017,377 | 497,917 | Star Voyage International Limited | 27 Jul 2026 |
Schedules 13D/G Reported by Xuncheng Chen:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.